-Anticoagulation after intracoronary stent implantation-

C Bode1, T K Nordt, W Kübler

  • 1Medizinische Universitätsklinik III (Kardiologie), Heidelberg.

Herz
|February 1, 1996
PubMed

Insights

Intracoronary stents improve percutaneous transluminal coronary angioplasty outcomes but carry thrombosis risks. New antithrombotic strategies and stent designs are crucial for managing these risks and improving patient safety.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomaterials Science

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) success is limited by acute dissection/occlusion and chronic restenosis.
  • Intracoronary stents effectively manage acute complications and reduce restenosis but pose a risk of stent thrombosis due to thrombogenic surfaces.
  • Stent thrombosis is influenced by emergency implantation, low coronary blood flow, small vessel diameter, and multiple stent placements.

Purpose of the Study:

  • To review the role of anticoagulation and platelet inhibition in mitigating stent thrombosis.
  • To evaluate the efficacy and safety of various antithrombotic therapies post-stent implantation.
  • To explore emerging strategies for reducing stent thrombosis, including novel antithrombotics and stent designs.

Main Methods:

  • Review of major randomized studies (BENESTENT, STRESS) evaluating antithrombotic regimens.
  • Analysis of outcomes associated with combination therapies including aspirin, dipyridamole, dextran, heparin, and warfarin.
  • Examination of recent findings on aspirin and ticlopidine combination therapy and novel antithrombotic agents.

Main Results:

  • Early combination therapies (aspirin, dipyridamole, dextran, heparin, warfarin) led to high rates of bleeding and vascular complications.
  • Dipyridamole and dextran were found to not improve outcomes after stent implantation.
  • Aspirin and ticlopidine combination therapy has shown promise in reducing stent thrombosis rates.
  • Predictive markers for stent thrombosis have not yet been successfully identified.

Conclusions:

  • Optimal stent implantation may allow anticoagulation management without warfarin, reducing bleeding risks.
  • Despite accurate anticoagulation monitoring, stent thrombosis remains a concern.
  • Emerging antithrombotic agents (hirudin, antibody 7E3) and reduced thrombogenicity of new stents offer promising future directions for preventing stent thrombosis.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...